Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can)

Cancer Causes and Control

Volumn 24, Issue 1, 2013, Pages 107-116

  Lindkvist, Björn ^a,k   Almquist, Martin ^b   Bjørge, Tone ^c,d   Stocks, Tanja ^e,f   Borena, Wegene ^g   Johansen, Dorthe ^b   Hallmans, Göran ^e   Engeland, Anders ^c,d   Nagel, Gabriele ^h   Jonsson, Håkan ^e   Selmer, Randi ^d   Diem, Guenter ⁱ   Häggström, Christel ^e   Tretli, Steinar ^j   Stattin, Pär ^e   Manjer, Jonas ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF BERGEN   (Norway)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^e UMEÅ UNIVERSITY   (Sweden)

^f The Capital Region   (Denmark)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^h UNIVERSITY OF ULM   (Germany)

ⁱ AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

^j CANCER REGISTRY OF NORWAY   (Norway)

^k SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Cohort study; CONOR; Epidemiology; Gastric adenocarcinoma; Metabolic syndrome

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STOMACH ADENOCARCINOMA; TRIACYLGLYCEROL BLOOD LEVEL;

ADENOCARCINOMA; ADULT; AGED; AUSTRIA; COHORT STUDIES; FEMALE; HUMANS; MALE; META-ANALYSIS AS TOPIC; METABOLIC SYNDROME X; MIDDLE AGED; NEOPLASMS; NORWAY; PROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; SWEDEN;

EID: 84871776513     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0096-6     Document Type: Article

References (57)

1. Forman D, Burley VJ (2006) Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res 20:633-649 (Pubitemid 44391336)
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917
3. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (Pubitemid 40372904)
4. Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49:347-353 (Pubitemid 32802568)
5. Tsugane S, Sasazuki S (2007) Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 10:75-83 (Pubitemid 46955941)
6. Gonzalez CA, Pera G, Agudo A et al (2003) Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer 107:629-634 (Pubitemid 37296125)
7. Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ et al (2005) The metabolic syndrome: a concept hard to define. Arch Med Res 36:223-231 (Pubitemid 40755135)
8. Lorenzo C, Williams K, Hunt KJ, Haffner SM (2007) The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30:8-13 (Pubitemid 46052493)
9. Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169:1505-1522 (Pubitemid 351181984)
10. Sturmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ (2006) Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomarkers Prev 15:2391-2397 (Pubitemid 46048295)
11. Russo A, Autelitano M, Bisanti L (2008) Metabolic syndrome and cancer risk. Eur J Cancer 44:293-297
12. Tian T, Zhang LQ, Ma XH, Zhou JN, Shen J (2012) Diabetes mellitus and incidence and mortality of gastric cancer: a meta-analysis. Exp Clin Endocrinol Diabetes 120:217-223
13. Jung MK, Jeon SW, Cho CM et al (2008) Hyperglycaemia, hypercholesterolaemia and the risk for developing gastric dysplasia. Dig Liver Dis 40:361-365
14. Jansson C, Johansson AL, Bergdahl IA et al (2005) Occupational exposures and risk of esophageal and gastric cardia cancers among male Swedish construction workers. Cancer Causes Control 16:755-764 (Pubitemid 41110967)
15. Kuriyama S, Tsubono Y, Hozawa A et al (2005) Obesity and risk of cancer in Japan. Int J Cancer 113:148-157 (Pubitemid 39507322)
16. Lindblad M, Rodriguez LA, Lagergren J (2005) Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 16:285-294 (Pubitemid 40897847)
17. Tretli S, Robsahm TE (1999) Height, weight and cancer of the oesophagus and stomach: a follow-up study in Norway. Eur J Cancer Prev 8:115-122 (Pubitemid 29210216)
18. Leren P, Askevold EM, Foss OP et al (1975) The Oslo study. Cardiovascular disease in middle-aged and young Oslo men. Acta Med Scand Suppl 588:1-38
19. Lund Haheim L, Wisloff TF, Holme I, Nafstad P (2006) Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol 164:769-774 (Pubitemid 44522081)
20. Naess O, Sogaard AJ, Arnesen E et al (2008) Cohort profile: cohort of Norway (CONOR). Int J Epidemiol 37:481-485 (Pubitemid 351804000)
21. Aires N, Selmer R, Thelle D (2003) The validity of self-reported leisure time physical activity, and its relationship to serum cholesterol, blood pressure and body mass index. A population based study of 332,182 men and women aged 40-42 years. Eur J Epidemiol 18:479-485 (Pubitemid 36899551)
22. Rapp K, Schroeder J, Klenk J et al (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49:945-952
23. Lindahl B, Weinehall L, Asplund K, Hallmans G (1999) Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals. Diabetes Care 22:1988-1992 (Pubitemid 30433977)
24. Berglund G, Eriksson KF, Israelsson B et al (1996) Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmo Preventive Project. J Intern Med 239:489-497
25. Berglund G, Nilsson P, Eriksson KF et al (2000) Long-term outcome of the Malmo preventive project: mortality and cardiovascular morbidity. J Intern Med 247:19-29 (Pubitemid 30073160)
26. Stocks T, Borena W, Strohmaier S et al (2010) Cohort Profile: the metabolic syndrome and cancer project (Me-Can). Int J Epidemiol 39:660-667
27. Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48:27-33
28. Larsen IK, Småstuen M, Parkin DM, Bray F (2007) Data quality at the Cancer Registry of Norway. In: Cancer in Norway 2006 - cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway, Oslo
29. The Swedish Board of Health and Welfare (2010) Cancerregistret - Kodningsinstruktion 2010. The Swedish Board of Health and Welfare, Stockholm
30. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1, diagnosis and classification of diabetes mellitus. World Health Organization, Geneva
31. World Health Organization (2000) Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organization, Geneva
32. Wood AM, White I, Thompson SG, Lewington S, Danesh J (2006) Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol 35:1570-1578 (Pubitemid 46178936)
33. Clarke R, Shipley M, Lewington S et al (1999) Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 150:341-353 (Pubitemid 29383482)
34. Johansen D, Stocks T, Jonsson H et al (2010) Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. Cancer Epidemiol Biomarkers Prev 19:2307-2317
35. Di Angelantonio E, Kaptoge S, Liwington S et al (2009) Fibrinogen Studies Collaboration. Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies. Stat Med 28:1067-1092
36. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194-202 (Pubitemid 40095870)
37. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:1871-1877 (Pubitemid 44455170)
38. Kuriki K, Hirose K, Tajima K (2007) Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev 16:83-89 (Pubitemid 46105011)
39. Tseng CH (2011) Diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan. Gut 60:774-779
40. Adami HO, McLaughlin J, Ekbom A et al (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control CCC 2:307-314
41. Swerdlow AJ, Laing SP, Qiao Z et al (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92:2070-2075 (Pubitemid 40897432)
42. Ogunleye AA, Ogston SA, Morris AD, Evans JM (2009) A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 101:1199-1201
43. Wideroff L, Gridley G, Mellemkjaer L et al (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89:1360-1365 (Pubitemid 27418027)
44. Yamagata H, Kiyohara Y, Nakamura S et al (2005) Impact of fasting plasma glucose levels on gastric cancer incidence in a general Japanese population: the Hisayama study. Diabetes Care 28:789-794 (Pubitemid 40434474)
45. Ikeda F, Doi Y, Yonemoto K et al (2009) Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology 136:1234-1241
46. Lin SW, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers. Cancer Epidemiol Biomarkers Prev 20:954-961
47. Stocks T, Rapp K, Bjorge T et al (2009) Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med 6:e1000201
48. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215-244 (Pubitemid 32275588)
49. Dossus L, Kaaks R (2008) Nutrition, metabolic factors and cancer risk. Best Pract Res Clin Endocrinol Metab 22:551-571
50. Thompson MA, Cox AJ, Whitehead RH, Jonas HA (1990) Autocrine regulation of human tumor cell proliferation by insulin-like growth factor II: an in vitro model. Endocrinology 126:3033-3042 (Pubitemid 20216558)
51. Wolk A, Gridley G, Svensson M et al (2001) A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12:13-21 (Pubitemid 32125897)
52. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354-362 (Pubitemid 43329250)
53. Chow WH, Blot WJ, Vaughan TL et al (1998) Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 90:150-155 (Pubitemid 28114417)
54. Lagergren J, Bergstrom R, Nyren O (1999) Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130:883-890 (Pubitemid 29239582)
55. Vaughan TL, Davis S, Kristal A, Thomas DB (1995) Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 4:85-92
56. Lagergren J, Bergstrom R, Lindgren A, Nyren O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825-831 (Pubitemid 29142625)
57. Larsen IK, Smastuen M, Johannesen TB et al (2009) Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 45:1218-1231